{
    "xml": "<topic id=\"PHP428\" outputclass=\"drug\" rev=\"1.14\" type=\"drug\" namespace=\"/drugs/misoprostol\" basename=\"misoprostol\" title=\"MISOPROSTOL\">\n<title>MISOPROSTOL</title>\n<body>\n<data name=\"vtmid\">43684009</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP49802\" outputclass=\"drugAction\" rev=\"1.12\" parent=\"/drugs/misoprostol\">\n<title>Drug action</title>\n<body>\n<section>\n<sectiondiv>\n<p>Misoprostol is a synthetic prostaglandin analogue that has antisecretory and protective properties, promoting healing of gastric and duodenal ulcers. It also acts as a potent uterine stimulant.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49334\" outputclass=\"indicationsAndDose\" rev=\"1.33\" parent=\"/drugs/misoprostol\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Benign gastric ulceration</p>\n<p outputclass=\"therapeuticIndication\">Benign duodenal ulceration</p>\n<p outputclass=\"therapeuticIndication\">NSAID-associated ulceration</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>800&#8239;micrograms daily in 2&#8211;4 divided doses continued for at least 4 weeks or may be continued for up to 8 weeks if required, dose to be taken with breakfast (or main meals) and at bedtime.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Prophylaxis of NSAID-induced gastric ulcer</p>\n<p outputclass=\"therapeuticIndication\">Prophylaxis of duodenal ulcer</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>200&#8239;micrograms 4 times a day, reduced if not tolerated to 200&#8239;micrograms 2&#8211;3 times a day, use lower dose is less effective.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Termination of pregnancy following mifepristone (gestation up to 49 days)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>400&#8239;micrograms for 1 dose, dose to be given 24&#8211;48 hours after mifepristone.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Termination of pregnancy following mifepristone (gestation 50 to 63 days)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by vagina or by buccal administration or by sublingual administration</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>800&#8239;micrograms for 1 dose, dose to be given 24&#8211;48 hours after mifepristone, if abortion has not occurred 4 hours after first misoprostol dose a further dose may be given, (by mouth or by vagina) 400&#8239;micrograms for 1 dose.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Termination of pregnancy following mifepristone (gestation of 9 to 13 weeks)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by vagina</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>800&#8239;micrograms for 1 dose, dose to be given 36&#8211;48 hours after mifepristone, followed by (by vagina or by mouth) 400&#8239;micrograms every 3&#8239;hours if required for a maximum of 4 doses.</p>\n</li>\n</ul>\n</section>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Termination of pregnancy following mifepristone (gestation of 13 to 24 weeks)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">Initially by vagina</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>800&#8239;micrograms for 1 dose, dose to be given 36&#8211;48 hours after mifepristone, followed by (by vagina or by mouth) 400&#8239;micrograms every 3&#8239;hours if required for a maximum of 4 doses, if abortion has not occurred 3 hours after the last dose of misoprostol, a further dose of mifepristone may be given, and misoprostol may be recommenced 12 hours later.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP34796\" outputclass=\"unlicensedUse\" rev=\"1.9\" parent=\"/drugs/misoprostol\">\n<title>Unlicensed use</title>\n<body>\n<section>\n<sectiondiv>\n<p>Use of misoprostol for termination of pregnancy is an unlicensed use.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP50375\" outputclass=\"cautions\" rev=\"1.7\" parent=\"/drugs/misoprostol\">\n<title>Cautions</title>\n<body>\n<section outputclass=\"cautions\">\n<p>\n<ph outputclass=\"caution\">Conditions where hypotension might precipitate severe complications (e.g. cerebrovascular disease, cardiovascular disease)</ph>; <ph outputclass=\"caution\">inflammatory bowel disease</ph>\n</p>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35063\" outputclass=\"sideEffects\" rev=\"1.13\" parent=\"/drugs/misoprostol\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"commonOrVeryCommon\">\n<p outputclass=\"title\">Common or very common</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Diarrhoea</ph>\n</p>\n</sectiondiv>\n<sectiondiv outputclass=\"notKnown\">\n<p outputclass=\"title\">Frequency not known</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Abdominal pain</ph>; <ph outputclass=\"sideEffect\">abnormal vaginal bleeding</ph>; <ph outputclass=\"sideEffect\">dizziness</ph>; <ph outputclass=\"sideEffect\">dyspepsia</ph>; <ph outputclass=\"sideEffect\">flatulence</ph>; <ph outputclass=\"sideEffect\">intermenstrual bleeding</ph>; <ph outputclass=\"sideEffect\">menorrhagia</ph>; <ph outputclass=\"sideEffect\">nausea</ph>; <ph outputclass=\"sideEffect\">postmenopausal bleeding</ph>; <ph outputclass=\"sideEffect\">rashes</ph>; <ph outputclass=\"sideEffect\">vomiting</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n<section outputclass=\"sideEffectsAdvice\">\n<title>Side-effects, further information</title>\n<sectiondiv>\n<p outputclass=\"title\">Diarrhoea</p>\n<p>May occasionally be severe and require withdrawal, reduced by giving single doses not exceeding 200&#8239;micrograms and by avoiding magnesium-containing antacids.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP50183\" outputclass=\"conceptionAndContraception\" parent=\"/drugs/misoprostol\">\n<title>Conception and contraception</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises that misoprostol should not be used in women of childbearing age unless pregnancy has been excluded. In such patients it is advised that misoprostol should only be used if the patient takes <i>effective contraceptive measures</i> and has been advised of the <i>risks of taking misoprostol if pregnant.</i>\n</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP49069\" outputclass=\"pregnancy\" parent=\"/drugs/misoprostol\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Avoid&#8212;potent uterine stimulant (has been used to induce abortion).</p>\n<p>Teratogenic risk in first trimester.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP50610\" outputclass=\"breastFeeding\" parent=\"/drugs/misoprostol\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Present in milk, but amount probably too small to be harmful.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP428-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/misoprostol\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75982\" title=\"Tablet\" namespace=\"/drugs/misoprostol/tablet\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101324\" title=\"Vaginal delivery system\" namespace=\"/drugs/misoprostol/vaginal-delivery-system\">Vaginal delivery system</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP88003\" namespace=\"/drugs/diclofenac-sodium-with-misoprostol\" title=\"DICLOFENAC SODIUM WITH MISOPROSTOL\" count=\"1\" rel=\"backlink\">DICLOFENAC SODIUM WITH MISOPROSTOL</xref>\n<xref format=\"dita\" scope=\"local\" type=\"drug\" href=\"#PHP88090\" namespace=\"/drugs/misoprostol-with-naproxen\" title=\"MISOPROSTOL WITH NAPROXEN\" count=\"1\" rel=\"backlink\">MISOPROSTOL WITH NAPROXEN</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78207\" namespace=\"/treatment-summaries/peptic-ulceration\" title=\"Peptic ulceration\" count=\"3\" rel=\"backlink\">Peptic ulceration</xref>\n<xref format=\"dita\" scope=\"local\" type=\"treatmentSummary\" href=\"#PHP78629\" namespace=\"/treatment-summaries/obstetrics\" title=\"Obstetrics\" count=\"4\" rel=\"backlink\">Obstetrics</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP75982\" namespace=\"/drugs/misoprostol/tablet\" title=\"Tablet\" count=\"1\" rel=\"link\">Tablet</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP101324\" namespace=\"/drugs/misoprostol/vaginal-delivery-system\" title=\"Vaginal delivery system\" count=\"1\" rel=\"link\">Vaginal delivery system</xref>\n</links>\n</topic>",
    "id": "PHP428",
    "outputclass": "drug",
    "rev": "1.14",
    "type": "drug",
    "namespace": "/drugs/misoprostol",
    "basename": "misoprostol",
    "title": "MISOPROSTOL",
    "vtmid": "43684009",
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "drugAction": {
        "drugAction": [
            {
                "type": "drugAction",
                "textContent": "Misoprostol is a synthetic prostaglandin analogue that has antisecretory and protective properties, promoting healing of gastric and duodenal ulcers. It also acts as a potent uterine stimulant.",
                "html": "<p>Misoprostol is a synthetic prostaglandin analogue that has antisecretory and protective properties, promoting healing of gastric and duodenal ulcers. It also acts as a potent uterine stimulant.</p>"
            }
        ]
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Benign gastric ulceration",
                        "html": "Benign gastric ulceration"
                    },
                    {
                        "textContent": "Benign duodenal ulceration",
                        "html": "Benign duodenal ulceration"
                    },
                    {
                        "textContent": "NSAID-associated ulceration",
                        "html": "NSAID-associated ulceration"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "800 micrograms daily in 2&#8211;4 divided doses continued for at least 4 weeks or may be continued for up to 8 weeks if required, dose to be taken with breakfast (or main meals) and at bedtime.",
                        "html": "<p>800&#8239;micrograms daily in 2&#8211;4 divided doses continued for at least 4 weeks or may be continued for up to 8 weeks if required, dose to be taken with breakfast (or main meals) and at bedtime.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Prophylaxis of NSAID-induced gastric ulcer",
                        "html": "Prophylaxis of NSAID-induced gastric ulcer"
                    },
                    {
                        "textContent": "Prophylaxis of duodenal ulcer",
                        "html": "Prophylaxis of duodenal ulcer"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "200 micrograms 4 times a day, reduced if not tolerated to 200 micrograms 2&#8211;3 times a day, use lower dose is less effective.",
                        "html": "<p>200&#8239;micrograms 4 times a day, reduced if not tolerated to 200&#8239;micrograms 2&#8211;3 times a day, use lower dose is less effective.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Termination of pregnancy following mifepristone (gestation up to 49 days)",
                        "html": "Termination of pregnancy following mifepristone (gestation up to 49 days)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "400 micrograms for 1 dose, dose to be given 24&#8211;48 hours after mifepristone.",
                        "html": "<p>400&#8239;micrograms for 1 dose, dose to be given 24&#8211;48 hours after mifepristone.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Termination of pregnancy following mifepristone (gestation 50 to 63 days)",
                        "html": "Termination of pregnancy following mifepristone (gestation 50 to 63 days)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially vagina or buccal administration or sublingual administration"
                    ],
                    "textContent": "Initially by vagina or by buccal administration or by sublingual administration",
                    "html": "Initially by vagina or by buccal administration or by sublingual administration"
                },
                "adult": [
                    {
                        "textContent": "800 micrograms for 1 dose, dose to be given 24&#8211;48 hours after mifepristone, if abortion has not occurred 4 hours after first misoprostol dose a further dose may be given, (by mouth or by vagina) 400 micrograms for 1 dose.",
                        "html": "<p>800&#8239;micrograms for 1 dose, dose to be given 24&#8211;48 hours after mifepristone, if abortion has not occurred 4 hours after first misoprostol dose a further dose may be given, (by mouth or by vagina) 400&#8239;micrograms for 1 dose.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Termination of pregnancy following mifepristone (gestation of 9 to 13 weeks)",
                        "html": "Termination of pregnancy following mifepristone (gestation of 9 to 13 weeks)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially vagina"
                    ],
                    "textContent": "Initially by vagina",
                    "html": "Initially by vagina"
                },
                "adult": [
                    {
                        "textContent": "800 micrograms for 1 dose, dose to be given 36&#8211;48 hours after mifepristone, followed by (by vagina or by mouth) 400 micrograms every 3 hours if required for a maximum of 4 doses.",
                        "html": "<p>800&#8239;micrograms for 1 dose, dose to be given 36&#8211;48 hours after mifepristone, followed by (by vagina or by mouth) 400&#8239;micrograms every 3&#8239;hours if required for a maximum of 4 doses.</p>"
                    }
                ]
            },
            {
                "indications": [
                    {
                        "textContent": "Termination of pregnancy following mifepristone (gestation of 13 to 24 weeks)",
                        "html": "Termination of pregnancy following mifepristone (gestation of 13 to 24 weeks)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "Initially vagina"
                    ],
                    "textContent": "Initially by vagina",
                    "html": "Initially by vagina"
                },
                "adult": [
                    {
                        "textContent": "800 micrograms for 1 dose, dose to be given 36&#8211;48 hours after mifepristone, followed by (by vagina or by mouth) 400 micrograms every 3 hours if required for a maximum of 4 doses, if abortion has not occurred 3 hours after the last dose of misoprostol, a further dose of mifepristone may be given, and misoprostol may be recommenced 12 hours later.",
                        "html": "<p>800&#8239;micrograms for 1 dose, dose to be given 36&#8211;48 hours after mifepristone, followed by (by vagina or by mouth) 400&#8239;micrograms every 3&#8239;hours if required for a maximum of 4 doses, if abortion has not occurred 3 hours after the last dose of misoprostol, a further dose of mifepristone may be given, and misoprostol may be recommenced 12 hours later.</p>"
                    }
                ]
            }
        ]
    },
    "unlicensedUse": {
        "unlicensedUse": [
            {
                "type": "unlicensedUse",
                "textContent": "Use of misoprostol for termination of pregnancy is an unlicensed use.",
                "html": "<p>Use of misoprostol for termination of pregnancy is an unlicensed use.</p>"
            }
        ]
    },
    "cautions": {
        "cautions": [
            {
                "type": "cautions",
                "textContent": "Conditions where hypotension might precipitate severe complications (e.g. cerebrovascular disease, cardiovascular disease)",
                "html": "Conditions where hypotension might precipitate severe complications (e.g. cerebrovascular disease, cardiovascular disease)"
            },
            {
                "type": "cautions",
                "textContent": "inflammatory bowel disease",
                "html": "inflammatory bowel disease"
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "commonOrVeryCommon": [
                    {
                        "type": "commonOrVeryCommon",
                        "textContent": "Diarrhoea",
                        "html": "Diarrhoea",
                        "frequency": "commonOrVeryCommon",
                        "specificity": {
                            "textContent": "Common or very common",
                            "html": "Common or very common"
                        }
                    }
                ],
                "notKnown": [
                    {
                        "type": "notKnown",
                        "textContent": "Abdominal pain",
                        "html": "Abdominal pain",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "abnormal vaginal bleeding",
                        "html": "abnormal vaginal bleeding",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dizziness",
                        "html": "dizziness",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "dyspepsia",
                        "html": "dyspepsia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "flatulence",
                        "html": "flatulence",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "intermenstrual bleeding",
                        "html": "intermenstrual bleeding",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "menorrhagia",
                        "html": "menorrhagia",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "nausea",
                        "html": "nausea",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "postmenopausal bleeding",
                        "html": "postmenopausal bleeding",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "rashes",
                        "html": "rashes",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    },
                    {
                        "type": "notKnown",
                        "textContent": "vomiting",
                        "html": "vomiting",
                        "frequency": "notKnown",
                        "specificity": {
                            "textContent": "Frequency not known",
                            "html": "Frequency not known"
                        }
                    }
                ]
            }
        },
        "advice": [
            {
                "type": "advice",
                "title": "Diarrhoea",
                "textContent": "May occasionally be severe and require withdrawal, reduced by giving single doses not exceeding 200 micrograms and by avoiding magnesium-containing antacids.",
                "html": "<p>May occasionally be severe and require withdrawal, reduced by giving single doses not exceeding 200&#8239;micrograms and by avoiding magnesium-containing antacids.</p>"
            }
        ]
    },
    "conceptionAndContraception": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises that misoprostol should not be used in women of childbearing age unless pregnancy has been excluded. In such patients it is advised that misoprostol should only be used if the patient takes effective contraceptive measures and has been advised of the risks of taking misoprostol if pregnant.",
                "html": "<p>Manufacturer advises that misoprostol should not be used in women of childbearing age unless pregnancy has been excluded. In such patients it is advised that misoprostol should only be used if the patient takes <i>effective contraceptive measures</i> and has been advised of the <i>risks of taking misoprostol if pregnant.</i>\n</p>"
            }
        ]
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Avoid&#8212;potent uterine stimulant (has been used to induce abortion).\n\nTeratogenic risk in first trimester.",
                "html": "<p>Avoid&#8212;potent uterine stimulant (has been used to induce abortion).</p><p>Teratogenic risk in first trimester.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Present in milk, but amount probably too small to be harmful.",
                "html": "<p>Present in milk, but amount probably too small to be harmful.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ]
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP75982",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP101324",
                "label": "Vaginal delivery system",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drug": [
            {
                "id": "PHP88003",
                "label": "DICLOFENAC SODIUM WITH MISOPROSTOL",
                "type": "drug"
            },
            {
                "id": "PHP88090",
                "label": "MISOPROSTOL WITH NAPROXEN",
                "type": "drug"
            }
        ],
        "treatmentSummary": [
            {
                "id": "PHP78207",
                "label": "Peptic ulceration",
                "type": "treatmentSummary"
            },
            {
                "id": "PHP78629",
                "label": "Obstetrics",
                "type": "treatmentSummary"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP75982",
                "label": "Tablet",
                "type": "medicinalForm"
            },
            {
                "id": "PHP101324",
                "label": "Vaginal delivery system",
                "type": "medicinalForm"
            }
        ]
    }
}